Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Alvarado-Miranda et al. Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer. Curr. Oncol. 2023, 30, 6097-6110.
Alvarado-Miranda A, Lara-Medina FU, Muñoz-Montaño WR, Zinser-Sierra JW, Galeana PAC, Garza CV, Sanchez Benitez D, Limón Rodríguez JA, Arce Salinas CH, Guijosa A, Arrieta O. Alvarado-Miranda A, et al. Among authors: guijosa a. Curr Oncol. 2024 Nov 15;31(11):7177-7179. doi: 10.3390/curroncol31110529. Curr Oncol. 2024. PMID: 39590178 Free PMC article.
Representation of Low- and Middle-Income Countries in CKD Drug Trials: A Systematic Review.
Cojuc-Konigsberg G, Guijosa A, Moscona-Nissan A, Nordmann-Gomes A, Canaviri-Flores VA, Braverman-Poyastro A, de la Fuente-Ramírez R, Tinajero-Sánchez D, de Las Fuentes Cepeda A, Noyola-Pérez A, Lozano R, Correa-Rotter R, Ramírez-Sandoval JC. Cojuc-Konigsberg G, et al. Among authors: guijosa a. Am J Kidney Dis. 2024 Aug 6:S0272-6386(24)00902-8. doi: 10.1053/j.ajkd.2024.06.012. Online ahead of print. Am J Kidney Dis. 2024. PMID: 39117096
Diagnostic accuracy of the BioFire® FilmArray® pneumonia panel in COVID-19 patients with ventilator-associated pneumonia.
Cojuc-Konigsberg G, Moscona-Nissan A, Guijosa A, Mireles Dávalos CD, Martínez MEJ, Mújica Sánchez MA, Hernández Huizar VF, Durán Barrón MA, Gómez KV, Andrade-Galindo R, Ordóñez-Oviedo M, Brito GD, Vargas EB. Cojuc-Konigsberg G, et al. Among authors: guijosa a. BMC Infect Dis. 2023 Aug 9;23(1):524. doi: 10.1186/s12879-023-08486-4. BMC Infect Dis. 2023. PMID: 37559032 Free PMC article.
Capecitabine Plus Aromatase Inhibitor as First Line Therapy for Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer.
Alvarado-Miranda A, Lara-Medina FU, Muñoz-Montaño WR, Zinser-Sierra JW, Galeana PAC, Garza CV, Sanchez Benitez D, Limón Rodríguez JA, Arce Salinas CH, Guijosa A, Arrieta O. Alvarado-Miranda A, et al. Among authors: guijosa a. Curr Oncol. 2023 Jun 24;30(7):6097-6110. doi: 10.3390/curroncol30070454. Curr Oncol. 2023. PMID: 37504314 Free PMC article.
Examining the Role of Histaminergic, Orexinergic, and Cannabinergic Systems in Redox Regulation in Gastric Adenocarcinoma.
Torres-Román AL, Rodríguez-Flores KL, Hernández-Mora VM, Ruiz-García E, Prospero-García O, Guijosa A, Molina A, Morales-Mulia M, Aschner M, Santamaría A, Ortega-Gómez A. Torres-Román AL, et al. Among authors: guijosa a. Mini Rev Med Chem. 2023;23(18):1806-1817. doi: 10.2174/1389557523666230221104504. Mini Rev Med Chem. 2023. PMID: 36809932 Review.
Characterization of triple negative breast cancer gene expression profiles in Mexican patients.
Ortiz Valdez E, Rangel-Escareño C, Matus Santos JA, Vázquez Romo R, Guijosa A, Villarreal-Garza C, Arrieta O, Rodríguez-Bautista R, Caro-Sánchez CH, Ortega Gómez A. Ortiz Valdez E, et al. Among authors: guijosa a. Mol Clin Oncol. 2022 Dec 15;18(1):5. doi: 10.3892/mco.2022.2601. eCollection 2023 Jan. Mol Clin Oncol. 2022. PMID: 36605097 Free PMC article.